Multicomponent System: A Novel Approach in Cocrystal Techniques for Improving the Solubility of Poorly Soluble Drugs

ABSTRACT

Poor solubility in modern pharmaceuticals has been a significant barrier to achieving optimal oral bioavailability. A majority of drug substances and New Chemical Entities (NCEs) are classified under BCS (Biopharmaceutical Classification System) Class II or Class IV. Cocrystals, which are multicomponent systems comprising an Active Pharmaceutical Ingredient (API) and one or more coformers in a specific stoichiometric ratio, have been utilized to address this issue. Furthermore, cocrystals and multicomponent systems have been developed to deliver Fixed-Dose Combinations (FDCs) of two or more drugs simultaneously, leading to the emergence of Drug-Drug Cocrystals (DDCs). They have helped in improving the bioavailability and efficacy of APIs by improving solubility and other factors such as tabletability and flow property. The eventual approval and the release of products such as Beta-Chlor, Suglat, Steglatro, Entresto, Setglujan, and Seglentis demonstrates the capability of DDCs to deliver fixed-dose combinations while achieving success in the market. This review provides a brief introduction to cocrystals as multicomponent systems and describes the feasibility of multicomponent systems, documented research on multicomponent systems and DDCs, identification methods and marketed approvals of DDCs.

KEYWORDS

• Cocrystals
• Multicomponent Systems
• Dissolution Enhancement
• Improved
• Physicochemical Properties

Showing references and in-text citations exactly as published.

• DOI10.5530/ijper.20257037Copy

RELATED ARTICLES

Matched on section and article type within this issue of IJPER.

• Review · VOLUME 59, ISSUE 2Pharmacotherapy of Anorexia Nervosa and Bulimia Nervosa Using SSRIs, MAOIs and TCAsSripriya Sanil · pp. 425–432Review ArticleSame type: Review
• Review · VOLUME 59, ISSUE 2Fostering Ethical Decision-Making Skills in Pharmaceutical Education: Vital for Future PharmacistsThota Suguna Leelavati, Sripathi Madhavi, Shaik Aminabee · pp. 433–440Review ArticleSame type: Review
• Review · VOLUME 59, ISSUE 2Pro-Inflammatory Cytokines Predict the Response of Cancer TreatmentUmar Farooq Mir, Deepak Kumar Jha, Sandipan Chatterjee · pp. 441–452Review ArticleSame type: Review
• Review · VOLUME 59, ISSUE 2Deciphering Molecular Insights into Isocitrate Lyase and their Inhibitors: A Detailed Display through Medicinal Chemistry WindowGritika Khanojia, Vinayak Walhekar, Patil Ashwini, Pratik Birajdar, Pawar Ritesh, Amol Muthal, Subhash Bodhankar, Chandrakant Bagul, Dileep Kumar, Baswaraju Macha, Vaibhav Shinde, Ravindra Kulkarni · pp. 453–471Review ArticleSame type: Review